Summary:
- Researchers are investigating a potential correlation between the use of GLP-1 receptor agonists (such as Ozempic and Wegovy) and a decline in sperm quality or male reproductive health.
- While initial animal studies have raised concerns regarding testicular function and hormone regulation, scientists emphasize that more robust, peer-reviewed clinical trials in humans are necessary to confirm these findings and determine causality.